2019. Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S37. DOI:https://doi.org/10.25251/skin.3.supp.37.